In recent years, patients taking GLP-1 agonists such as Ozempic and Mounjaro have reported unexpected side effects related to addiction, including a decreased desire to smoke or drink. This has led to speculation that these drugs could be used as anti-addiction medications, offering hope for patients struggling with addiction.
As an addiction researcher, Christian Hendershot notes that there are limited medications available for treating addiction and many patients face challenges accessing them. Research funding for addiction is also lower compared to other diseases. However, the potential of GLP-1 drugs in combating addiction has generated interest among healthcare providers working in this field, with the hope of providing more effective treatment options for patients in need.
While the effects of GLP-1 agonists on pregnancy are still unknown, taking these drugs can help reduce insulin resistance and improve fertility in patients. It is important for patients to discuss their plans for pregnancy with their doctors and consider additional contraceptive methods before starting any medication that may affect their ability to conceive.
